(Q40738483)

23 September 2017

title

Adiponectin regulates psoriasiform skin inflammation by suppressing IL-17 production from γδ-T cells (English)

1 reference

23 September 2017

0 references

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26173479%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

author name string

Sayaka Shibata

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26173479%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Yayoi Tada

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26173479%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Carren Sy Hau

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26173479%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Aya Mitsui

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26173479%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Yoshihide Asano

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26173479%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Makoto Sugaya

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26173479%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Takafumi Kadono

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26173479%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Yosuke Masamoto

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26173479%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Mineo Kurokawa

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26173479%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Toshimasa Yamauchi

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26173479%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Naoto Kubota

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26173479%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Takashi Kadowaki

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26173479%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Shinichi Sato

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26173479%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

language of work or name

English

0 references

publication date

15 July 2015

1 reference

23 September 2017

published in

Nature Communications

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26173479%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26173479%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

page(s)

7687

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26173479%20AND%20SRC:MED&resulttype=core&format=json

Psoriasis: epidemiology, clinical features, and quality of life

14 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8687

Psoriasis and psoriatic arthritis: clinical features and disease mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8687

The IL-23/Th17 axis in the immunopathogenesis of psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8687

T-helper 17 cells in psoriatic plaques and additional genetic links between IL-23 and psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8687

IL-17 targeted therapies for psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8687

Ustekinumab, an anti-IL-12/23 p40 monoclonal antibody, inhibits radiographic progression in patients with active psoriatic arthritis: results of an integrated analysis of radiographic data from the phase 3, multicentre, randomised, double-blind, pla

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8687

Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8687

The concept of psoriasis as a systemic inflammation: implications for disease management

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8687

Psoriasis and metabolic disease: epidemiology and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8687

Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8687

Long-term prognosis in patients with psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8687

Cardiovascular mortality in psoriasis and psoriatic arthritis: epidemiology, pathomechanisms, therapeutic implications, and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8687

The cellular and signaling networks linking the immune system and metabolism in disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8687

Inflammation and metabolic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8687

Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8687

The role of the novel adipocyte-derived hormone adiponectin in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8687

Adiponectin as an anti-inflammatory factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8687

Anti-inflammatory and anti-atherogenic properties of adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8687

Adiponectin prevents progression of steatohepatitis in mice by regulating oxidative stress and Kupffer cell phenotype polarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8687

Adiponectin promotes macrophage polarization toward an anti-inflammatory phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8687

Adiponectin primes human monocytes into alternative anti-inflammatory M2 macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8687

The levels of adiponectin and leptin and their relation to other markers of cardiovascular risk in patients with psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8687

Serum high molecular weight adiponectin levels are decreased in psoriasis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8687

Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8687

Pivotal role of dermal IL-17-producing γδ T cells in skin inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8687

TLRs to cytokines: mechanistic insights from the imiquimod mouse model of psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8687

IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8687

Rorγt+ innate lymphocytes and γδ T cells initiate psoriasiform plaque formation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8687

Deficiency in IL-17-committed Vγ4(+) γδ T cells in a spontaneous Sox13-mutant CD45.1(+) congenic mouse substrain provides protection from dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8687

Adiponectin receptor as a key player in healthy longevity and obesity-related diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8687

Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8687

A novel role for adiponectin in regulating the immune responses in chronic hepatitis C virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8687

Adiponectin is a negative regulator of antigen-activated T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8687

Adiponectin inhibits LPS-induced NF-kappaB activation and IL-6 production and increases PPARgamma2 expression in adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8687

Adiponectin decreases C-reactive protein synthesis and secretion from endothelial cells: evidence for an adipose tissue-vascular loop

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8687

Role of anti-inflammatory adipokines in obesity-related diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8687

The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8687

Macrophage adiponectin expression improves insulin sensitivity and protects against inflammation and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8687

Lack of adiponectin leads to increased lymphocyte activation and increased disease severity in a mouse model of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8687

Pulmonary inflammation induced by subacute ozone is augmented in adiponectin-deficient mice: role of IL-17A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8687

The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8687

gammadelta T cells: an important source of IL-17.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8687

IL-17 in obesity and adipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8687

Elevated proinflammatory cytokine production by a skewed T cell compartment requires monocytes and promotes inflammation in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8687

Obesity predisposes to Th17 bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8687

The imbalance of Th17/Th1/Tregs in patients with type 2 diabetes: relationship with metabolic factors and complications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8687

New insights in the immunologic basis of psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8687

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8687

Tracing the movement of adiponectin in a parabiosis model of wild-type and adiponectin-knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8687

Disruption of adiponectin causes insulin resistance and neointimal formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8687

Developmental regulation of T-cell receptor gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8687

Anti-CD4 monoclonal antibody treatment of moderate to severe psoriasis vulgaris: results of a pilot, multicenter, multiple-dose, placebo-controlled study

21 January 2018

1 reference

12 December 2020

Plasma adiponectin and leptin levels in Japanese patients with psoriasis

1 reference

12 December 2020

The 'psoriatic march': a concept of how severe psoriasis may drive cardiovascular comorbidity

1 reference

12 December 2020

Circulating levels of adiponectin, oxidized LDL and C-reactive protein in Portuguese patients with psoriasis vulgaris, according to body mass index, severity and duration of the disease

1 reference

12 December 2020

Adiponectin as an anti-inflammatory factor in the pathogenesis of psoriasis: induction of elevated serum adiponectin levels following therapy

1 reference

12 December 2020

Adiponectin accumulates in myocardial tissue that has been damaged by ischemia-reperfusion injury via leakage from the vascular compartment

1 reference

12 December 2020

Psoriasis and metabolic syndrome

1 reference

12 December 2020

Systematic review of interleukin-12, interleukin-17, and interleukin-23 pathway inhibitors for the treatment of moderate-to-severe chronic plaque psoriasis: ustekinumab, briakinumab, tildrakizumab, guselkumab, secukinumab, ixekizumab, and brodalumab

1 reference

12 December 2020

Overexpression of adiponectin receptors potentiates the antiinflammatory action of subeffective dose of globular adiponectin in vascular endothelial cells

1 reference

12 December 2020

Differential developmental requirement and peripheral regulation for dermal Vγ4 and Vγ6T17 cells in health and inflammation

1 reference

12 December 2020

Increased activity of interleukin-23/interleukin-17 proinflammatory axis in obese women

1 reference

12 December 2020

Psoriasis Vulgaris Lesions Contain Discrete Populations of Th1 and Th17 T Cells

1 reference

12 December 2020

Increased prevalence of psoriasis in patients with coronary artery disease: results from a case-control study

1 reference

12 December 2020